Chandler Park, M.D., HMH oncologist and hematologist, recently participated in a panel presentation at the Markey Cancer Center Affiliate Network 2017 Cancer Care Conference in Lexington, Ky.
Park, a member of the University of Kentucky Markey Cancer Center Molecular Tumor Board, contributed his voice to the presentation “Molecular Tumor Boards: An Evidence-based Approach to Precision Medicine.” The presentation included:
- Description of technological advances enabling precision medicine;
- Discussion of how healthcare systems in the Markey Cancer Center Affiliate Network collaborate with the Molecular Tumor Board; and
- Discussion of clinical next generation sequencing reports and development of patient care plans for targeted therapy.
The Molecular Tumor Board is a multidisciplinary body that uses genetic analysis to help oncologists choose cancer therapies tailored to each patient’s individual needs.
Learn more about the University of Kentucky Markey Cancer Center Molecular Tumor Board.